322 related articles for article (PubMed ID: 28426102)
21. Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma.
Whittle SB; Williamson KC; Russell HV
Pediatr Hematol Oncol; 2017 Aug; 34(5):331-342. PubMed ID: 29200325
[TBL] [Abstract][Full Text] [Related]
22. A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group study.
Krance RA; Newman EM; Ravindranath Y; Harris MB; Brecher M; Wimmer R; Shuster JJ; Land VJ; Pullen J; Crist W
Cancer; 1991 Feb; 67(3):550-6. PubMed ID: 1985748
[TBL] [Abstract][Full Text] [Related]
23. Acute respiratory infections in children and adolescents with acute lymphoblastic leukemia.
Hakim H; Dallas R; Zhou Y; Pei D; Cheng C; Flynn PM; Pui CH; Jeha S
Cancer; 2016 Mar; 122(5):798-805. PubMed ID: 26700662
[TBL] [Abstract][Full Text] [Related]
24. Comparison of myelosuppression using the D-index between children and adolescents/young adults with acute lymphoblastic leukemia during induction chemotherapy.
Matsushima S; Kobayashi R; Sano H; Hori D; Yanagi M; Kodama K; Suzuki D; Kobayashi K
Pediatr Blood Cancer; 2021 Feb; 68(2):e28763. PubMed ID: 33047887
[TBL] [Abstract][Full Text] [Related]
25. Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia.
Patel PA; DeGroote NP; Jackson K; Cash T; Castellino SM; Jaggi P; Esbenshade AJ; Miller TP
Cancer; 2022 Dec; 128(23):4129-4138. PubMed ID: 36238979
[TBL] [Abstract][Full Text] [Related]
26. Infections occurring during the courses of anticancer chemotherapy in children with ALL: a retrospective analysis of 59 patients.
Rahiala J; Perkkiö M; Riikonen P
Pediatr Hematol Oncol; 1998; 15(2):165-74. PubMed ID: 9592843
[TBL] [Abstract][Full Text] [Related]
27. Pattern of bloodstream infections in patients with hematological malignancies in a tertiary care centre.
Bansal S; Advani SH
Indian J Cancer; 2014; 51(4):447-9. PubMed ID: 26842155
[TBL] [Abstract][Full Text] [Related]
28. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.
Pui CH; Boyett JM; Hughes WT; Rivera GK; Hancock ML; Sandlund JT; Synold T; Relling MV; Ribeiro RC; Crist WM; Evans WE
N Engl J Med; 1997 Jun; 336(25):1781-7. PubMed ID: 9187068
[TBL] [Abstract][Full Text] [Related]
29. A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Japan Adult Leukemia Study Group.
Ohno R; Tomonaga M; Ohshima T; Masaoka T; Asou N; Oh H; Nishikawa K; Kanamaru A; Murakami H; Furusawa S
Int J Hematol; 1993 Aug; 58(1-2):73-81. PubMed ID: 7693029
[TBL] [Abstract][Full Text] [Related]
30. Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia.
Place AE; Pikman Y; Stevenson KE; Harris MH; Pauly M; Sulis ML; Hijiya N; Gore L; Cooper TM; Loh ML; Roti G; Neuberg DS; Hunt SK; Orloff-Parry S; Stegmaier K; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2018 Jul; 65(7):e27062. PubMed ID: 29603593
[TBL] [Abstract][Full Text] [Related]
31. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC).
Hann I; Viscoli C; Paesmans M; Gaya H; Glauser M
Br J Haematol; 1997 Dec; 99(3):580-8. PubMed ID: 9401070
[TBL] [Abstract][Full Text] [Related]
32. Infections during induction therapy of protocol CCLG-2008 in childhood acute lymphoblastic leukemia: a single-center experience with 256 cases in China.
Li SD; Chen YB; Li ZG; Wu RH; Qin MQ; Zhou X; Jiang J; Zhang RD; Xie J; Ma XL; Zhang R; Wang B; Wu Y; Zheng HY; Wu MY
Chin Med J (Engl); 2015 Feb; 128(4):472-6. PubMed ID: 25673448
[TBL] [Abstract][Full Text] [Related]
33. Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
Schrappe M; Bleckmann K; Zimmermann M; Biondi A; Möricke A; Locatelli F; Cario G; Rizzari C; Attarbaschi A; Valsecchi MG; Bartram CR; Barisone E; Niggli F; Niemeyer C; Testi AM; Mann G; Ziino O; Schäfer B; Panzer-Grümayer R; Beier R; Parasole R; Göhring G; Ludwig WD; Casale F; Schlegel PG; Basso G; Conter V
J Clin Oncol; 2018 Jan; 36(3):244-253. PubMed ID: 29148893
[TBL] [Abstract][Full Text] [Related]
34. Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia.
Karol SE; Sun Y; Tang L; Pui CH; Ferrolino J; Allison KJ; Cross SJ; Evans WE; Crews KR; Jeha S; Wolf J
Cancer Med; 2020 Sep; 9(18):6550-6555. PubMed ID: 32710497
[TBL] [Abstract][Full Text] [Related]
35. Induction toxicity of a modified Memorial Sloan-Kettering-New York II Protocol in children with relapsed acute lymphoblastic leukemia: a single institution study.
Morland BJ; Shaw PJ
Med Pediatr Oncol; 1996 Sep; 27(3):139-44. PubMed ID: 8699989
[TBL] [Abstract][Full Text] [Related]
36. A retrospective analysis of complications observed in children with acute lymphoblastic leukemia during chemotherapy.
Canbolat Ayhan A; Timur C; Kalaycik O
Minerva Pediatr; 2017 Apr; 69(2):95-105. PubMed ID: 26200521
[TBL] [Abstract][Full Text] [Related]
37. Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
Michel G; Landman-Parker J; Auclerc MF; Mathey C; Leblanc T; Legall E; Bordigoni P; Lamagnere JP; Demeocq F; Perel Y; Auvrignon A; Berthou C; Bauduer F; Pautard B; Schneider P; Schaison G; Leverger G; Baruchel A
J Clin Oncol; 2000 Apr; 18(7):1517-24. PubMed ID: 10735900
[TBL] [Abstract][Full Text] [Related]
38. Survival Outcome of Filipino Children With Acute Lymphoblastic Leukemia Treated With Modified Berlin-Frankfurt-Muenster/Hong Kong Acute Lymphoblastic Leukemia (BFM95/HKALL97) Protocol in a Tertiary General Hospital From January 2005 to December 2009: A Retrospective Cohort Study.
Dujua AC; Hernandez FG
J Pediatr Hematol Oncol; 2017 Apr; 39(3):e116-e123. PubMed ID: 28085747
[TBL] [Abstract][Full Text] [Related]
39. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
Leahey AM; Bunin NJ; Belasco JB; Meek R; Scher C; Lange BJ
Med Pediatr Oncol; 2000 May; 34(5):313-8. PubMed ID: 10797352
[TBL] [Abstract][Full Text] [Related]
40. Causative Pathogens of Febrile Neutropaenia in Children Treated for Acute Lymphoblastic Leukaemia.
Lam JC; Chai JY; Wong YL; Tan NW; Ha CT; Chan MY; Tan AM
Ann Acad Med Singap; 2015 Nov; 44(11):530-4. PubMed ID: 27089960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]